asco 2021 lung recap: lurbinectedin in small cell lung cancer and the failed atlantis trial
Published 2 years ago • 618 plays • Length 5:27Download video MP4
Download video MP3
Similar videos
-
6:10
asco 2021 lung recap: circulatory tumor dna
-
6:38
asco 2021 lung recap: poseidon trial: durvalumab /- tremelimumab vs. chemo alone
-
4:45
the skyscraper trial: treatments for extensive stage small cell lung cancer - asco lung review 2022
-
8:08
asco 2021 lung recap: mylung consortium: overall biomarker testing
-
11:30
asco 2021 lung recap: surgical outcomes & checkmate 816: nivolumab in early stage nsclc
-
8:13
asco 2021 lung recap: fda analysis of immunotherapy with or without chemo in adv nsclc and low pdl-1
-
5:31
novel therapies in small cell lung cancer (sclc): lurbinectedin
-
8:35
asco lung cancer roundtable - nsclc - the cityscape trial: anti tigit & immune checkpoint inhibitor
-
5:26
asco 2021 lung recap: codebreak 100: sotorasib in kras g12c mutation
-
5:24
asco 2019 lung cancer roundtable - lurbinectedin - how promising is this for relapsed sclc
-
16:41
asco lung cancer roundtable - trial updates in nsclc - adaura trial and post surgery egfr mutation
-
4:09
asco lung cancer highlights, part 7: maintenance therapy for small cell lung cancer?
-
7:44
asco lung cancer highlights, part 1: introduction to stage iii nsclc
-
5:20
asco lung cancer highlights, pt 11: nintedanib with second line chemotherapy
-
11:58
asco lung cancer roundtable - mesothelioma updates
-
11:41
the adaura trial: flaws and results - leading developments & current questions in lung cancer
-
14:43
the need for molecular testing in lung cancer - asco lung review 2022
-
12:34
asco lung cancer roundtable - nsclc - the sindas trial: addition of sbrt to a systemic tki for egfr